Host-pathogen Interactions During SARS-CoV-2 Infection

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions
Infection, CoronavirusSevere Acute Respiratory Syndrome Coronavirus 2
Interventions
BIOLOGICAL

Blood sample

blood samples will be taken as below: Group E1: At day 0 Group E2: At day 0, day 7, day 14 Group E3: At day 0

BIOLOGICAL

Low or upper respiratory tract sample

"Low or upper respiratory tract sample will be collected in order to take virology measurements:~Group E1: At day 0 Group E2: At day 0, day 7, day 14 Group E3: At day 0"

BIOLOGICAL

Stool collection or fecal swab

"The stool collection or fecal swab will be collected in order to take virology measurements:~Group E1: / Group E2: At day 0, day 7, day 14 Group E3: At day 0"

OTHER

phone call

phone calls will be performed to collect data regarding patients' symptoms at: Group E1: Day 14 Group E3: Day 14

Trial Locations (12)

38300

Groupement Hospitalier Nord-Daupine, Bourgoin

38700

Centre Hospitalo-Universitaire de Grenoble, La Tronche

42270

Hôpital Nord de Saint Etienne, Saint-Priest-en-Jarez

44093

Hôpital mère - enfant Nantes, Nantes

69317

Hopital de la Croix-Rousse, Lyon

69437

Hôpital Edouard Herriot, Lyon

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

69655

Hôpital Nord-Ouest, Villefranche-sur-Saône

69677

Hôpital femme-mère-enfant, Bron

Hôpital Louis Pradel, Bron

74370

Centre Hospitalier D'Annecy-Genevois, Épagny

92700

Hôpital Louis Mourier, Colombes

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04376476 - Host-pathogen Interactions During SARS-CoV-2 Infection | Biotech Hunter | Biotech Hunter